The role of the nursing team in the care of patients with Kabuki syndrome

• Autorzy: Struzik M. , Gawlik M.
• Języki publikacji: EN

Abstrakty

EN

Background: Kabuki syndrome is a rare genetic condition characterised by pathological changes within all the systems of the body, but with variable gene expression. All the patients described in the literature so far have specific facial features resembling the masks of actors from the Japanese Kabuki Theatre and mild to moderate mental impairment. Diagnosis is made based by genetic testing for mutations of the KMT2D and KDM6A genes. Therapy is mainly based on symptomatic alleviation of the effects of mutation, rehabilitation and improvement of the quality of patients’ life. Then prognosis of patients with Kabuki syndrome is closely related to the severity of symptoms, which is very variable. Aim of the study: The purpose of the study is to present the nursing problems based on the case report and to present complications caused by the disease entity. Material and methods: The criterion for including the patient in the study was the legal guardian’s (parent’s) consent for the child to participate in the study. Qualitative research was conducted using analysis of medical records, interview with the child and the child’s legal guardian, direct and indirect observation of the child for psycho-social changes related to the disease and interpretation of the data in the context of the theoretical knowledge and our own observations. Case report: The report is based on the case of a 16-year-old girl, diagnosed (at the age of fourteen) with rare genetic disorder – Kabuki syndrome. The patient experiences some characteristic symptoms – big, red lips, lowset and sticky-out ears, drooping eyelids and short fingers and toes. One of the first symptoms suggesting Kabuki syndrome were: spitting up during breastfeeding, problems with swallowing, motor clumsiness and epilepsy. The role of the nursing team during hospitalization was to take care because of habitual dislocation of patella, and to provide psychological suport. At present time the girl uses a wheelchair or she moves on her knees Results: The manifestations of chronic disease contribute to the feeling of excessive stress, regardless of the patient’s age. An adequate diet enriched with proteins contributes to the prevention of bedsores among individuals with Kabuki syndrome, immobilised to various degrees. Regular consultations with specialists, such as cardiologist, neurologist, gastroenterologist, orthopaedist, ophthalmologist, psychologist, orthodontist, speech therapist, immunologist, endocrinologist and dietician reduce the risk of complications associated with the disease in the patient with Kabuki syndrome. Early implementation of rehabilitation, focused to increase muscle tension, contributes to maintaining autonomy and self-care in patients with Kabuki syndrome.

• Wydawca: -
• Czasopismo: Medical Science Pulse
• Rocznik: 2018
• Tom: 12
• Numer: 3
• Opis fizyczny: p.36-41,ref.

Twórcy

autor

Struzik M.

• Opole Medical School, Opole, Poland

autor

Gawlik M.

• Panstwowa Medyczna Wyzsza Szkoła Zawodowa w Opolu, Katowicka 68, 45-060 Opole, Poland

Bibliografia

• 1. Miyake N, Koshimizu E, Okamoto N, Mizuno S, Ogata T, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet A 2013 Sep; 161A(9): 2234–2243.
• 2. Sobreira N, Brucato M, Zhang L. Patients with a Kabuki syndrome phenotype demonstrate DNA methylation abnormalities. Eur J Hum Genet 2017 Dec; 25(12): 1335–1344.
• 3. Armstrong L, Abd El Moneim A, Aleck K, Aughton DJ, Baumann C, et al. Further Delineaction of Kabuki Syndrome in 48 Well-Defined New Individuals. Am J Med Genet A. 2005 Jan 30; 132A(3): 265–272.
• 4. Cheon CK, Ko JM. Kabuki syndrome: clinical and molecular characteristics. Korean J Pediatr 2015; 58(9): 317–324.
• 5. Dentici ML, Di Pede A, Lepri FR, et al. Kabuki syndrome: clinical and molecular diagnosis in the first year of life. Arch Dis Child 2015; 100: 158–164.
• 6. Sakata S, Okada S, Aoyama K, Hara K, Tani C, et al. Individual clinically diagnosed with CHARGE syndrome but with a mutation in KMT2D, a gene associated with Kabuki syndrome: a case report. Front Genet 2017 Dec 11; 8: 210.
• 7. Jamsheer A. Genetyczne podłoże izolowanych wrodzonych wad dłoni. Med Wieku Rozw 2008; 12(3): 729–737. (in Polish).
• 8. Maksymowicz A. Internet jako wsparcie dla chorych na choroby rzadkie. Media i Społeczeństwo. 2016; 6: 113–117. (in Polish).
• 9. Stowarzyszenie „Neuron” Pomocy Dzieciom i Osobom Niepełnosprawnym [online] 2001 [cit. 21.10.2018]. Available from URL: http://ngo.dabrowa-gornicza.pl/baza/baza_ngo/organizacja/136/stowarzyszenie_neuron_pomocy_dzieciom_i_osobom_niepelnosprawnym.html. (in Polish).
• 10. Florek-Łuszczki M, Lachowski S. Działania instytucjonalne na rzecz osób niepełnosprawnych. Medycyna Ogólna i Nauki o Zdrowiu 2013: 4(19): 480–484.
• 11. Liu S, Hong X, Shen C, Shi Q, Wang J, et al. Kabuki syndrome: a Chinese case series and systematic review of the spectrum of mutations. BMC Med Genet 2015 Apr 21; 16: 26.
• 12. Ziarko M. Zmaganie się ze stresem choroby przewlekłej. Poznań: UAM; 2014: 31–47. (in Polish).
• 13. Schulz Y, Freese L, Mänz J, Zoll B, Völter C, et al. CHARGE and Kabuki syndromes: a phenotypic and molecular link. Hum Mol Genet 2014; 23(16): 4396–4405.
• 14. Sun XX, Li SS, Zhang M, Xie QM, Xu JH, et.al. Association of HSP90B1 genetic polymorphisms with efficacy of glucocorticoids and improvement of HRQoL in systemic lupus erythematosus patients from Anhui Province. Am J Clin Exp Immunol 2018; 7(2): 27–39.
• 15. Szeląg J, Strzałkowska A, Ślęzak R. Zepół Kabuki – opis przypadku. Pediatr Pol 2005: 80(9): 817–821. (in Polish).
• 16. Boss RD, Falck A, Goloff N, Hutton N, Miles A, et.al. Low prevalence of palliative care and ethics consultations for children with chronic critical illness. Acta Paediatr 2018 Oct; 107(10): 1832–1833.
• 17. Błoch M, Śmigiel R. Heterogenność kliniczna zespołu Kabuki (zespół Niikawy i Kurokiego) na podstawie opisu przypadku 15-letniej pacjentki z nawykowym zwichnięciem rzepek. Pediatria Polska 2017: 92(6): 758–763. (in Polish).
• 18. Szczepaniak E, Obersztyn E, Kruk M, Jastrzębska-Janas K. Zespół Kabuki z padaczką ujawniającą się w 13 roku życia. Opis przypadku. Neurol Dziec 2006: 15(30): 69–74. (in Polish).
• 19. Lenartowicz H, Kózka M. Metodologia badań w pielęgniarstwie. Warszawa: Wydawnictwo Lekarskie PZWL; 2011: 97–108. (in Polish).
• 20. Caciolo C, Alfieri P, Piccini G, Digilio MC, Lepri FR, et al. Neurobehavioral features in individuals with Kabuki syndrome. Mol Genet Genomic Med. 2018 May; 6(3): 322–331.
• 21. Haller J, Kruk MR. Normal and abnormal aggression: human disorders and novel laboratory models. Neurosci Biobehav Rev 2006; 30(3): 292–303.
• 22. Cudzilo D, Czochrowska E. Orthodontic treatment of a Kabuki syndrome patient. Cleft Palate Craniofac J 2018 Sep; 55(8): 1175-1180.
• 23. Teranishi H, Koga Y, Nakashima K, Morihana E, Ishii K, et al. Cancer management in Kabuki syndrome: the first case of Wilms tumor and a literature review. J Pediatr Hematol Oncol 2018 Jul; 40(5): 391–394.
• 24. Lepri FR, Cocciadiferro D, Augello B, Alfieri P, Pes V, et al. Clinical and neurobehavioral features of three novel Kabuki syndrome patients with mosaic KMT2D mutations and a review of literature. Int J Mol Sci 2017 Dec 28; 19(1): 82.
• 25. Roma D, Palma P, Capolino R, Figà-Talamanca L, Diomedi-Camassei F, et al. Spinal ependymoma in a patient with Kabuki syndrome: a case report. BMC Med Genet 2015 Sep 5; 16: 80.
• 26. Bademci G, Cengiz FB, Foster li I, et.al. Variations in multiple syndromic deafness genes mimic non-syndromic hearing loss. Sci Rep 2016; 26(6) [online] 2016. [cit. 26.08.2016]. Available from URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999867/.
• 27. Skowrońska B, Fichna P, Majewska K, Stankiewicz W, Niedziela M. Zespół metaboliczny i cukrzyca typu 2 u 16-letniego chłopca – opis przypadku. Endokrynologia, Otyłość i Zaburzenia Przemiany Materii 2005; 3(1): 40–44. (in Polish).
• 28. Vajravelu ME, De León DD. Genetic characteristics of patients with congenital hyperinsulinism. Curr Opin Pediatr 2018 Aug; 30(4): 568–575.

Identyfikatory

DOI

10.5604/01.3001.0012.5180